{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:14:15Z","timestamp":1774908855482,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Health and Technology Program of Ningbo","award":["2023Y88"],"award-info":[{"award-number":["2023Y88"]}]},{"name":"the science and Technology Program of Xuzhou","award":["ZYSB20210086"],"award-info":[{"award-number":["ZYSB20210086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99038-0","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T13:32:00Z","timestamp":1745847120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A bioinformatics analysis and experimental validation of PDGFD as a promising diagnostic biomarker for acute myeloid leukemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Lulu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangshuang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijiang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianlei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"99038_CR1","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky, I. & Abdul-Hay, M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 6, e441. https:\/\/doi.org\/10.1038\/bcj.2016.50 (2016).","journal-title":"Blood Cancer J."},{"key":"99038_CR2","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N Engl. J. Med. 373, 1136\u20131152. https:\/\/doi.org\/10.1056\/NEJMra1406184 (2015).","journal-title":"N Engl. J. Med."},{"key":"99038_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s12015-021-10308-6","volume":"18","author":"NA Long","year":"2022","unstructured":"Long, N. A., Golla, U., Sharma, A. & Claxton, D. F. Acute myeloid leukemia stem cells: Origin, characteristics, and clinical implications. Stem Cell. Rev. 18, 1211\u20131226. https:\/\/doi.org\/10.1007\/s12015-021-10308-6 (2022).","journal-title":"Stem Cell. Rev."},{"key":"99038_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","volume":"16","author":"K Schepers","year":"2015","unstructured":"Schepers, K., Campbell, T. B. & Passegu\u00e9, E. Normal and leukemic stem cell niches: insights and therapeutic opportunities. Cell. Stem Cell. 16, 254\u2013267. https:\/\/doi.org\/10.1016\/j.stem.2015.02.014 (2015).","journal-title":"Cell. Stem Cell."},{"key":"99038_CR5","first-page":"44","volume":"2","author":"JB Demoulin","year":"2012","unstructured":"Demoulin, J. B. & Montano-Almendras, C. P. Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis. Am. J. Blood Res. 2, 44\u201356 (2012).","journal-title":"Am. J. Blood Res."},{"key":"99038_CR6","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1038\/sj.onc.1205319","volume":"21","author":"J Lotem","year":"2002","unstructured":"Lotem, J. & Sachs, L. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene 21, 3284\u20133294. https:\/\/doi.org\/10.1038\/sj.onc.1205319 (2002).","journal-title":"Oncogene"},{"key":"99038_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41568-020-0260-3","volume":"20","author":"M Yamashita","year":"2020","unstructured":"Yamashita, M., Dellorusso, P. V., Olson, O. C. & Passegu\u00e9, E. Dysregulated Haematopoietic stem cell behaviour in myeloid leukaemogenesis. Nat. Rev. Cancer. 20, 365\u2013382. https:\/\/doi.org\/10.1038\/s41568-020-0260-3 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"99038_CR8","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1038\/sj.leu.2400870","volume":"11","author":"M Tsuzuki","year":"1997","unstructured":"Tsuzuki, M. et al. Proliferative effects of several hematopoietic growth factors on acute myelogenous leukemia cells and correlation with treatment outcome. Leukemia 11, 2125\u20132130. https:\/\/doi.org\/10.1038\/sj.leu.2400870 (1997).","journal-title":"Leukemia"},{"key":"99038_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cytogfr.2018.08.004","volume":"43","author":"S Binder","year":"2018","unstructured":"Binder, S., Luciano, M. & Horejs-Hoeck, J. The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators. Cytokine Growth Factor. Rev. 43, 8\u201315. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.08.004 (2018).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"99038_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2017.03.003","volume":"614","author":"A Kazlauskas","year":"2017","unstructured":"Kazlauskas, A. PDGFs and their receptors. Gene 614, 1\u20137. https:\/\/doi.org\/10.1016\/j.gene.2017.03.003 (2017).","journal-title":"Gene"},{"key":"99038_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/ph3030572","volume":"3","author":"M Raica","year":"2010","unstructured":"Raica, M. & Cimpean, A. M. Platelet-derived growth factor (PDGF)\/PDGF receptors (PDGFR) Axis as target for antitumor and antiangiogenic therapy. Pharmaceuticals (Basel) 3, 572\u2013599. https:\/\/doi.org\/10.3390\/ph3030572 (2010).","journal-title":"Pharmaceuticals (Basel)"},{"key":"99038_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cytogfr.2004.03.007","volume":"15","author":"L Fredriksson","year":"2004","unstructured":"Fredriksson, L., Li, H. & Eriksson, U. The PDGF family: Four gene products form five dimeric isoforms. Cytokine Growth Factor. Rev. 15, 197\u2013204. https:\/\/doi.org\/10.1016\/j.cytogfr.2004.03.007 (2004).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"99038_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ijbiomac.2022.01.113","volume":"202","author":"X Zou","year":"2022","unstructured":"Zou, X. et al. Targeting the PDGF\/PDGFR signaling pathway for cancer therapy: A review. Int. J. Biol. Macromol. 202, 539\u2013557. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.113 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"99038_CR14","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2174\/13816128113199990592","volume":"20","author":"C Gialeli","year":"2014","unstructured":"Gialeli, C. et al. PDGF\/PDGFR signaling and targeting in cancer growth and progression: Focus on tumor microenvironment and cancer-associated fibroblasts. Curr. Pharm. Des. 20, 2843\u20132848. https:\/\/doi.org\/10.2174\/13816128113199990592 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"99038_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1365-2141.2002.03500.x","volume":"117","author":"RJ Su","year":"2002","unstructured":"Su, R. J. et al. Platelet-derived growth factor promotes ex vivo expansion of CD34\u2009+\u2009cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic\/severe combined immunodeficient repopulating cells and formation of adherent cells. Br. J. Haematol. 117, 735\u2013746. https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03500.x (2002).","journal-title":"Br. J. Haematol."},{"key":"99038_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1034\/j.1600-0609.2001.0430a.x","volume":"67","author":"B Foss","year":"2001","unstructured":"Foss, B., Ulvestad, E. & Bruserud, \u00d8. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. Eur. J. Haematol. 67, 267\u2013278. https:\/\/doi.org\/10.1034\/j.1600-0609.2001.0430a.x (2001).","journal-title":"Eur. J. Haematol."},{"key":"99038_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678. https:\/\/doi.org\/10.1038\/s41587-020-0546-8 (2020).","journal-title":"Nat. Biotechnol."},{"key":"99038_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/bioinformatics\/btab561","volume":"38","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. UCSCXenaShiny: An R\/CRAN package for interactive analysis of UCSC Xena data. Bioinformatics 38, 527\u2013529. https:\/\/doi.org\/10.1093\/bioinformatics\/btab561 (2022).","journal-title":"Bioinformatics"},{"key":"99038_CR19","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013w560. https:\/\/doi.org\/10.1093\/nar\/gkz430 (2019).","journal-title":"Nucleic Acids Res."},{"key":"99038_CR20","doi-asserted-by":"publisher","first-page":"D881","DOI":"10.1093\/nar\/gky1076","volume":"47","author":"FO Bagger","year":"2019","unstructured":"Bagger, F. O., Kinalis, S. & Rapin, N. BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles. Nucleic Acids Res. 47, D881\u2013d885. https:\/\/doi.org\/10.1093\/nar\/gky1076 (2019).","journal-title":"Nucleic Acids Res."},{"key":"99038_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy, B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br. J. Pharmacol. 181, 362\u2013374. https:\/\/doi.org\/10.1111\/bph.16257 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"99038_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002 (2017).","journal-title":"Neoplasia"},{"key":"99038_CR23","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar, S. V., Straub, P., Wang, J. & Zhang, B. LinkedOmics: Analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 46, D956\u2013d963. https:\/\/doi.org\/10.1093\/nar\/gkx1090 (2018).","journal-title":"Nucleic Acids Res."},{"key":"99038_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"99038_CR25","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"99038_CR26","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013d592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucleic Acids Res."},{"key":"99038_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell. Syst."},{"key":"99038_CR28","doi-asserted-by":"publisher","unstructured":"Lin, A. et al. CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Brief. Bioinform. 23 https:\/\/doi.org\/10.1093\/bib\/bbac129 (2022).","DOI":"10.1093\/bib\/bbac129"},{"key":"99038_CR29","doi-asserted-by":"publisher","unstructured":"Damiani, D. & Tiribelli, M. Present and future role of immune targets in acute myeloid leukemia. Cancers (Basel). 15 https:\/\/doi.org\/10.3390\/cancers15010253 (2022).","DOI":"10.3390\/cancers15010253"},{"key":"99038_CR30","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun, D. et al. TISCH: A comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 49, D1420\u2013d1430. https:\/\/doi.org\/10.1093\/nar\/gkaa1020 (2021).","journal-title":"Nucleic Acids Res."},{"key":"99038_CR31","doi-asserted-by":"publisher","unstructured":"Huang, C. et al. ScCancerExplorer: A comprehensive database for interactively exploring single-cell multi-omics data of human pan-cancer. Nucleic Acids Res. gkae1100. https:\/\/doi.org\/10.1093\/nar\/gkae1100 (2024).","DOI":"10.1093\/nar\/gkae1100"},{"key":"99038_CR32","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of drug sensitivity in cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013961. https:\/\/doi.org\/10.1093\/nar\/gks1111 (2013).","journal-title":"Nucleic Acids Res."},{"key":"99038_CR33","doi-asserted-by":"publisher","first-page":"110036","DOI":"10.1016\/j.cellsig.2021.110036","volume":"84","author":"O Contreras","year":"2021","unstructured":"Contreras, O., C\u00f3rdova-Casanova, A. & Brandan, E. PDGF-PDGFR network differentially regulates the fate, migration, proliferation, and cell cycle progression of myogenic cells. Cell. Signal. 84, 110036. https:\/\/doi.org\/10.1016\/j.cellsig.2021.110036 (2021).","journal-title":"Cell. Signal."},{"key":"99038_CR34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.yexcr.2016.10.022","volume":"349","author":"R Gallini","year":"2016","unstructured":"Gallini, R., Lindblom, P., Bondjers, C., Betsholtz, C. & Andrae, J. PDGF-A and PDGF-B induces cardiac fibrosis in Transgenic mice.  Exp. Cell. Res. 349, 282\u2013290. https:\/\/doi.org\/10.1016\/j.yexcr.2016.10.022 (2016).","journal-title":"Exp. Cell. Res."},{"key":"99038_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2013.05.002","volume":"19","author":"Y Cao","year":"2013","unstructured":"Cao, Y. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis. Trends Mol. Med. 19, 460\u2013473. https:\/\/doi.org\/10.1016\/j.molmed.2013.05.002 (2013).","journal-title":"Trends Mol. Med."},{"key":"99038_CR36","doi-asserted-by":"publisher","unstructured":"Michael, B. & Kristian, P. PDGF family function and prognostic value in tumor biology. Biochem. Biophys. Res. Commun. 503, 984\u2013990. https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.106","DOI":"10.1016\/j.bbrc.2018.06.106"},{"key":"99038_CR37","doi-asserted-by":"publisher","unstructured":"Tiong, I. S. et al. How comparable are patient outcomes in the real-world with populations studied in pivotal AML trials? Blood Cancer J. 14 https:\/\/doi.org\/10.1038\/s41408-024-00996-x (2024).","DOI":"10.1038\/s41408-024-00996-x"},{"key":"99038_CR38","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/s41375-020-01058-4","volume":"35","author":"D Mart\u00ednez-Cuadr\u00f3n","year":"2021","unstructured":"Mart\u00ednez-Cuadr\u00f3n, D. et al. Evolving treatment patterns and outcomes in older patients (\u2265\u200960 years) with AML: Changing everything to change nothing? Leukemia 35, 1571\u20131585. https:\/\/doi.org\/10.1038\/s41375-020-01058-4 (2021).","journal-title":"Leukemia"},{"key":"99038_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00428-022-03430-4","volume":"482","author":"OK Weinberg","year":"2023","unstructured":"Weinberg, O. K. et al. The international consensus classification of acute myeloid leukemia. Virchows Arch. 482, 27\u201337. https:\/\/doi.org\/10.1007\/s00428-022-03430-4 (2023).","journal-title":"Virchows Arch."},{"key":"99038_CR40","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","volume":"36","author":"R Ranieri","year":"2022","unstructured":"Ranieri, R. et al. Current status and future perspectives in targeted therapy of NPM1-mutated AML. Leukemia 36, 2351\u20132367. https:\/\/doi.org\/10.1038\/s41375-022-01666-2 (2022).","journal-title":"Leukemia"},{"key":"99038_CR41","doi-asserted-by":"publisher","unstructured":"Hindley, A., Catherwood, M. A., McMullin, M. F. & Mills, K. I. Significance of NPM1 gene mutations in AML. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms221810040 (2021).","DOI":"10.3390\/ijms221810040"},{"key":"99038_CR42","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/ajh.26989","volume":"98","author":"B Falini","year":"2023","unstructured":"Falini, B. NPM1-mutated acute myeloid leukemia: new pathogenetic and therapeutic insights and open questions. Am. J. Hematol. 98, 1452\u20131464. https:\/\/doi.org\/10.1002\/ajh.26989 (2023).","journal-title":"Am. J. Hematol."},{"key":"99038_CR43","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2022.07.004","volume":"33","author":"S Zheng","year":"2023","unstructured":"Zheng, S., Wang, X., Zhao, D., Liu, H. & Hu, Y. Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications. Trends Cell. Biol. 33, 312\u2013323. https:\/\/doi.org\/10.1016\/j.tcb.2022.07.004 (2023).","journal-title":"Trends Cell. Biol."},{"key":"99038_CR44","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3892\/or.2012.1825","volume":"28","author":"T Qiu","year":"2012","unstructured":"Qiu, T., Qi, X., Cen, J. & Chen, Z. Rap1GAP alters leukemia cell differentiation, apoptosis and invasion in vitro. Oncol. Rep. 28, 622\u2013628. https:\/\/doi.org\/10.3892\/or.2012.1825 (2012).","journal-title":"Oncol. Rep."},{"key":"99038_CR45","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad, K., Khorshid, K., Soleymani Fard, H. R., Ghaffari, S. H. & S. & An overview of MicroRNAs: Biology, functions, therapeutics, and analysis methods. J. Cell. Physiol. 234, 5451\u20135465. https:\/\/doi.org\/10.1002\/jcp.27486 (2019).","journal-title":"J. Cell. Physiol."},{"key":"99038_CR46","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1111\/jocd.15147","volume":"21","author":"F Labarrade","year":"2022","unstructured":"Labarrade, F., Botto, J. M. & Imbert, I. M. miR-203 represses keratinocyte stemness by targeting survivin. J. Cosmet. Dermatol. 21, 6100\u20136108. https:\/\/doi.org\/10.1111\/jocd.15147 (2022).","journal-title":"J. Cosmet. Dermatol."},{"key":"99038_CR47","doi-asserted-by":"publisher","unstructured":"Fahim, S. A. et al. Inflammatory breast carcinoma: elevated MicroRNA miR-181b-5p and reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p expression as potential biomarkers with diagnostic value. Biomolecules 10 https:\/\/doi.org\/10.3390\/biom10071059 (2020).","DOI":"10.3390\/biom10071059"},{"key":"99038_CR48","first-page":"2387","volume":"8","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. miR-203a-3p promotes colorectal cancer proliferation and migration by targeting PDE4D. Am. J. Cancer Res. 8, 2387\u20132401 (2018).","journal-title":"Am. J. Cancer Res."},{"key":"99038_CR49","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12876-023-02912-2","volume":"23","author":"R Miao","year":"2023","unstructured":"Miao, R. et al. A novel long non-coding RNA XLOC_004787, is associated with migration and promotes cancer cell proliferation by downregulating mir-203a-3p in gastric cancer. BMC Gastroenterol. 23, 280. https:\/\/doi.org\/10.1186\/s12876-023-02912-2 (2023).","journal-title":"BMC Gastroenterol."},{"key":"99038_CR50","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/1078-0432.Ccr-19-3003","volume":"26","author":"L Tang","year":"2020","unstructured":"Tang, L. et al. Characterization of immune dysfunction and identification of prognostic immune-related risk factors in acute myeloid leukemia. Clin. Cancer Res. 26, 1763\u20131772. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-3003 (2020).","journal-title":"Clin. Cancer Res."},{"key":"99038_CR51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli, A. et al. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126, 458\u2013465. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.03027.x (2009).","journal-title":"Immunology"},{"key":"99038_CR52","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/cyto.b.21349","volume":"90","author":"N Aggarwal","year":"2016","unstructured":"Aggarwal, N., Swerdlow, S. H., TenEyck, S. P., Boyiadzis, M. & Felgar, R. E. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes. Cytometry B Clin. Cytom. 90, 349\u2013357. https:\/\/doi.org\/10.1002\/cyto.b.21349 (2016).","journal-title":"Cytometry B Clin. Cytom"},{"key":"99038_CR53","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cell.2017.11.037","volume":"172","author":"AD Barrow","year":"2018","unstructured":"Barrow, A. D. et al. Natural killer cells control tumor growth by sensing a growth factor. Cell 172, 534\u2013548e519. https:\/\/doi.org\/10.1016\/j.cell.2017.11.037 (2018).","journal-title":"Cell"},{"key":"99038_CR54","doi-asserted-by":"publisher","unstructured":"Ma, S. et al. PDGF-D-PDGFR\u03b2 signaling enhances IL-15-mediated human natural killer cell survival. Proc. Natl. Acad. Sci. U S A  119 https:\/\/doi.org\/10.1073\/pnas.2114134119 (2022).","DOI":"10.1073\/pnas.2114134119"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99038-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99038-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99038-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T01:02:26Z","timestamp":1746234146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99038-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99038-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the First Affiliated Hospital of Soochow University provided approval for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"14862"}}